Biotech company Artegraft is accusing renowned attorney James Tyrrell and his former firm, Latham & Watkins, of malpractice that cost the company more than $10 million. Artegraft claims Tyrrell and the firm convinced it to sue Johnson & Johnson in a contract dispute based on a legally unfounded patent theory. Latham says Artegraft was a savvy client that was aware of the risks and is now trying to avoid paying $1.6 million in bills. The litigation comes as Tyrrell leads a 30-lawyer exodus to Patton & Boggs.
Popularity: 4% [?]
Posted on Wednesday, April 26th, 2006. Filed under: Law Misc, Litigation
You can
leave a response, or
trackback from your own site.
Rate This Post - Vote Now!
Biotech company Artegraft is accusing renowned attorney James Tyrrell and his former firm, Latham & Watkins, of malpractice that cost the company more than $10 million. Artegraft claims Tyrrell and the firm convinced it to sue Johnson & Johnson in a contract dispute based on a legally unfounded patent theory. Latham says Artegraft was a savvy client that was aware of the risks and is now trying to avoid paying $1.6 million in bills. The litigation comes as Tyrrell leads a 30-lawyer exodus to Patton & Boggs.
Popularity: 1% [?]
Posted on Wednesday, April 26th, 2006. Filed under: In-House Counsel, Law Misc
You can
leave a response, or
trackback from your own site.
Rate This Post - Vote Now!
Biotech company Artegraft is accusing renowned attorney James Tyrrell and his former firm, Latham & Watkins, of malpractice that cost the company more than $10 million. Artegraft claims Tyrrell and the firm convinced it to sue Johnson & Johnson in a contract dispute based on a legally unfounded patent theory. Latham says Artegraft was a savvy client that was aware of the risks and is now trying to avoid paying $1.6 million in bills. The litigation comes as Tyrrell leads a 30-lawyer exodus to Patton & Boggs.
Popularity: 1% [?]
Posted on Wednesday, April 26th, 2006. Filed under: Business Law, Law Misc
You can
leave a response, or
trackback from your own site.
Rate This Post - Vote Now!
